News coverage about Exactech (NASDAQ:EXAC) has trended somewhat positive this week, Accern Sentiment reports. The research group rates the sentiment of press coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Exactech earned a media sentiment score of 0.12 on Accern’s scale. Accern also gave news headlines about the medical equipment provider an impact score of 44.4667506952373 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

These are some of the headlines that may have effected Accern Sentiment’s scoring:

EXAC has been the topic of a number of recent analyst reports. BidaskClub lowered shares of Exactech from a “sell” rating to a “strong sell” rating in a research note on Tuesday, January 30th. Robert W. Baird reiterated a “hold” rating and set a $49.00 price target on shares of Exactech in a research note on Thursday, December 7th. ValuEngine lowered shares of Exactech from a “buy” rating to a “hold” rating in a research note on Friday, December 1st. Finally, Zacks Investment Research upgraded shares of Exactech from a “sell” rating to a “hold” rating in a research note on Tuesday, December 26th. One analyst has rated the stock with a sell rating and five have issued a hold rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $49.00.

Exactech (NASDAQ EXAC) opened at $49.25 on Friday. Exactech has a one year low of $23.75 and a one year high of $50.95. The company has a current ratio of 4.08, a quick ratio of 2.09 and a debt-to-equity ratio of 0.06. The stock has a market cap of $707.53, a PE ratio of 4,925.00, a PEG ratio of 3.66 and a beta of 0.90.

ILLEGAL ACTIVITY WARNING: This news story was originally posted by Watch List News and is owned by of Watch List News. If you are accessing this news story on another website, it was stolen and republished in violation of US and international copyright and trademark legislation. The legal version of this news story can be accessed at

About Exactech

Exactech, Inc develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company’s segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines.

Insider Buying and Selling by Quarter for Exactech (NASDAQ:EXAC)

Receive News & Ratings for Exactech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exactech and related companies with's FREE daily email newsletter.